Medical device with coating that promotes endothelial cell adherence and differentiation
Compositions and methods are provided for producing a medical device such as a stent, a stent graft, a synthetic vascular graft, heart valves, coated with a biocompatible matrix which incorporates antibodies, antibody fragments, or small molecules, which recognize, bind to and/or interact with a progenitor cell surface antigen to immobilize the cells at the surface of the device. The coating on the device can also contain a compound or growth factor for promoting the progenitor endothelial cell to accelerate adherence, growth and differentiation of the bound cells into mature and functional endothelial cells on the surface of the device to prevent intimal hyperplasia. Methods for preparing such medical devices, compositions, and methods for treating a mammal with vascular disease such as restenosis, artherosclerosis or other types of vessel obstructions are disclosed.
1 - 71 . (canceled)
72 . An implantable medical device comprising a coating having at least one matrix layer comprising one or more polysaccharides.
73 . The implantable medical device of claim 72 , wherein the medical device comprises an endovascular prosthesis selected from the group consisting of stents, stent grafts, heart valves, catheters, vascular prosthetic filters, artificial hearts, external and internal left ventricular assist devices, and synthetic vascular grafts.
74 . The implantable medical device of claim 72 , wherein the implantable medical device further comprises a metallic substrate.
75 . The implantable medical device of claim 72 , wherein the one or more polysaccharides is a dextran or a modified dextran.
76 . The implantable medical device of claim 75 , wherein the modified dextran is functionalized carboxymethyldextran.
77 . The implantable medical device of claim 72 , wherein the at least one matrix is covalently attached to the surface of the medical device.
78 . The implantable medical device of claim 72 , wherein said coating further comprises an antibody, antibody fragment or combinations thereof which bind to a progenitor endothelial cell surface antigen in vivo.
79 . A stent comprising a coating which comprises one or more layers of a matrix comprising a polysaccharide which is covalently attached to the stent surface.
80 . The stent of claim 79 , wherein the polysaccharide is a dextran or a modified dextran.
81 . The stent of claim 80 , wherein the dextran is carboxymethyldextran.
82 . The stent of claim 79 , wherein said coating further comprises an antibody, antibody fragment or combinations thereof which bind to a progenitor endothelial cell surface antigen in vivo.
83 . A method for coating an implantable medical device, comprising the steps of
(a) applying a coating comprising a polysaccharide matrix to the implantable medical device, and
(b) covalently attaching said polysaccharide matrix to the implantable medical device.
84 . The method of claim 83 , wherein the polysaccharide is a dextran, or a modified dextran.
85 . The method of claim 84 , wherein the modified dextran is functionalized carboxymethyldextran.
86 . The method of claim 83 , wherein the implantable medical device comprises an endovascular prosthesis selected from the group consisting of stents, stent grafts, heart valves, catheters, vascular prosthetic filters, artificial hearts, external and internal left ventricular assist devices, and synthetic vascular grafts.
87 . The method of claim 83 , wherein the implantable medical device comprises a metallic substrate.
88 . A metallic endovascular prosthesis for percutaneous transluminal coronary angioplasty comprising a metallic substrate whose surface is coated at least partly with a polysaccharide compound, characterized in that the polysaccharide compound is bound covalently to the metallic surface.